Instructor: Anita Li

Anita Li
Biography:

M.S., BCBA

Anita Li is currently a doctoral candidate in the Psychology Department at Western Michigan University. She received a B.S. in Psychology from the University of Florida and an M.S. in Applied Behavior Analysis from Florida Institute of Technology. Since becoming a BCBA in 2013, she has served individuals on the autism spectrum in a variety of settings. She has also held numerous consulting positions and teaching appointments at universities. She has also held numerous consulting positions and teaching appointments at universities.

Anita has presented more than 30 papers and workshops, including invited addresses, at both national and international conferences in behavior analysis. She has served as WMU's student representative for the Association of Behavior Analysis International. In 2018, she was named the All University Graduate Research and Creative Scholar award recipient for her significant contributions to research. Anita has published her research in the Journal of Applied Behavior Analysis, Behavior Analysis in Practice, Experimental and Clinical Psychopharmacology and Behavior Analysis: Research and Practice. In addition, she has served as a guest editor for two special sections on the experimental analysis of behavior for Behavior Analysis: Research and Practice. Anita's research interests include applied behavior pharmacology, diversity issues and instructional design. She is a part-time instructor for and coordinator of WMU's general psychology course system, which enrolls approximately 750 students each semester. Anita consults for the University of Dayton as it develops its M.A. program in applied behavior analysis.


Classes by this instructor


Board Certified Behavior Analysts and Psychotropic Medications: Overview and Considerations for Current Practices
Board Certified Behavior Analysts and Psychotropic Medications: Overview and Considerations for Current Practices - BEHP1223 Provides a basic overview of typical antipsychotic medications used to treat symptoms of irritability in individuals diagnosed with autism spectrum disorder and typical methods of assessing irritability. Reviews responses from a 2017 survey provided to board-certified individuals regarding their typical practices regarding the monitoring of psychotropic medications in their clients. Also discusses additional considerations and strategies. 


May 1, 2020 to June 30, 2021, Canvas 2